The largest database of trusted experimental protocols

Crpmi

Manufactured by GE Healthcare
Sourced in United States, United Kingdom

The CRPMI is a compact and versatile lab equipment designed for use in various clinical and research settings. It is capable of performing automated cell counting and analysis tasks, providing reliable and consistent results. The CRPMI incorporates advanced technologies to ensure accurate and efficient performance.

Automatically generated - may contain errors

4 protocols using crpmi

1

Blood and Tissue Harvesting for Immunoassays

Check if the same lab product or an alternative is used in the 5 most similar protocols
Blood samples from the retro-orbital sinus were heparinized to prevent clotting. Blood volumes were recorded and then blood was centrifuged to collect and archive plasma for quantification of antibodies. Spleens and lymph nodes (inguinal and brachial) were harvested in Hanks’ Balanced Salt Solution (HBSS; GE Healthcare Life Sciences). Samples were kept on ice during transportation and processing. Single-cell suspensions were made by pressing spleens and lymph nodes between the frosted ends of glass slides. Erythrocytes in blood and spleens were lysed. Cells were counted using an improved Neubauer counting chamber using trypan blue dye exculsion to assess viability, which was consistently >90%. All cells were plated in RPMI-1640 medium containing 10% heat-inactivated bovine calf serum and penicillin/streptomycin (cRPMI; GE Healthcare Life Sciences) in 96-well round-bottom plates and were maintained at 4 °C during handling and centrifugation (500 g). Up to two million cells were added to each well. Samples were processed by the same individual to reduce technical variability and they were blinded to treatment groups to eliminate bias.
+ Open protocol
+ Expand
2

Single-cell Isolation and Preparation

Check if the same lab product or an alternative is used in the 5 most similar protocols
Blood sampled from the retro-orbital sinus was heparinized to prevent clotting, and the volumes were recorded. Samples were kept on ice during transportation and processing. Single-cell suspensions were made by pressing spleens between the frosted ends of glass microscope slides. Erythrocytes in blood and spleens were lysed. Cells were counted using an improved Neubauer counting chamber using trypan blue dye exclusion to assess viability, which was consistently >90%. All cells were plated in Roswell Park Memorial Institute (RPMI)-1640 medium containing 10% heat-inactivated bovine calf serum, 0.1% 2-mercaptoethanol, and penicillin/streptomycin (cRPMI; GE Healthcare Life Sciences) in 96-well round-bottom plates and were maintained at 4 °C during handling and centrifugation (500× g). Up to two million cells were added to each well of a 96-well plate. Samples were processed by the same individual to reduce technical variability.
+ Open protocol
+ Expand
3

Splenocyte Cytokine Profiling Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
Splenocytes were seeded (2 × 105/well) and stimulated with the NG-34 epitope (5 µg/mL); media cRPMI (as negative control) and concavalin A (1 µg/mL) (as positive control) (GE Healthcare, Marlborough, MA, USA). The supernatants were harvested after 72 h incubation at 37 °C and a 9-plex panel MSD standard Th1/Th2/Th17 which checks IFN-γ, TNF-α, IL- 5, IL-10, IL-13 and IL-17 cytokines together with two U-plex panels for IL-6 and IL-1β detection were ran following the manufacturer’s instructions (MSD, Rockville, MD, USA).
+ Open protocol
+ Expand
4

Calcium Flux in Activated B Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Splenocytes were rested in cRPMI for 20 mins at 37°C, before staining. Splenocytes from one genotype (5×106) were labeled with 1μg Cy5 dye in cRPMI (GE healthcare, Chalfont, UK) for 5 mins at room temperature and the other genotype was left unstained. Cy5 labeled cells were washed and mixed with unlabeled cells. These cells were then loaded with INDO-1 AM (Invitrogen) in RPMI media for 30 minutes at 37°C. Following washing the cells were stained with CD19 FITC, CD23 PE and CD21 PerCP Cy5.5 (all Biolegend) and resuspended in HBSS (Gibco) and kept on ice. Cells were then warmed to 37°C prior to running the sample and ran for 30 seconds to establish a baseline, 10μg/ml anti-IgM Fab2 (Jackson Immunoresearch, WestGrove, PA) was added at 30 seconds to stimulate B cells. At 2 minutes, 10mM CaCl2 (Sigma Aldrich, St. Louis, MO) was added and the cells run until 5 minutes. At 5 minutes 1μg/ml of ionomycin (EMD Biosciences, La Jolla, CA) was added and the sample run until 7 minutes.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!